Series C - Strive Health

Series C - Strive Health

Investment Firm

Overview

Strive Health is a value-based kidney care provider with an integrated system supporting the journey of individuals with kidney disease.

Announced Date

May 31, 2023

Funding Type

Series C

Highlights

Location

United States, North America

Social

Investor Lead

New Enterprise Associates

New Enterprise Associates

New Enterprise Associates is a convertible_note and debt and early_stage_venture and late_stage_venture and post_ipo and venture firm.

Participant Investors

6

Investor Name
Participant InvestorEcho Health Ventures
Participant InvestorAscension Ventures
Participant InvestorCapitalG
Participant InvestorRedpoint
Participant InvestorNew Enterprise Associates

Round Details and Background

Strive Health raised $166000000 on 2023-05-31 in Series C

Strive Health is a value-based kidney care provider with an integrated system supporting the journey of individuals with kidney disease.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 08, 2019
Series A - Strive Health
5-80.0M
Mar 16, 2021
Series B - Strive Health
6-140.0M
May 31, 2023
Series C - Strive Health
7-166.0M

Recent Activity

There is no recent news or activity for this profile.